Pennington Biomedical Research Center
Baton Rouge, Louisiana, 70808, United States
NCT Number: NCT03489226
Comparison of Capsimax™ 2mg and 4mg of capsicum extract vs. placebo on metabolic rate and satiety.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Not applicable
Baton Rouge, Louisiana, 70808, United States
Capsimax™ is a capsicum extract in a bead technology to avoid oral and gastric burning. Capsimax™ 2mg, Capsimax™ 4 mg and placebo was initially given as a single dose on an empty stomach with measures of metabolic rate, and satiety before and after and food intake at 1 hour after Capsimax™.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects excluded will:
Capsimax
Placebo
Meal
Time frame: up to 5 hours
Metabolic cart measurement difference before and after intervention
Time frame: Baseline to 4 hours
Difference in area under the curve from baseline of the Mean Visual Analog. Each question on the scale ranges from 0 to 100 mm. The two ends of the scale are anchored by the highest and lowest values (e.g. "the hungriest I have ever been" to "no hunger at all"). Some questions have high values on the right and others have high values on the left. Each question (hunger, fullness, prospective food intake and satisfaction) is a sub-scale. Each sub-scale is scored separately.
Time frame: 1 hour after intervention
Meal with unlimited portions
Pennington Biomedical Research Center
Other
A Pilot Study of the Effect of a Dietary Herbal Supplement Containing Capsaicin or Placebo on Satiety, Metabolic Rate and Food Intake in Healthy Adults.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05919979
Energy Metabolism
Granada, Spain
View Trial DetailsNCT06754306
Behavior, Energy Metabolism
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT01209572
Computer Simulation, Energy Expenditure
Clermont-Ferrand, Auvergne, France
View Trial DetailsNCT07164014
Energy Metabolism, Glucose Metabolism Disorders
Riyadh, Saudi Arabia
View Trial Details